Saral Jeevan Bima
Saral Jeevan Bima is a standardised, pure-term life insurance product mandated by IRDAI effective January 1, 2021, designed to provide a uniform minimum feature set across all life insurers to simplify customer choice and reduce complexity in term insurance.
Before Saral Jeevan Bima, the term insurance market offered hundreds of products with varying definitions, exclusions, optional riders, and underwriting criteria. A consumer comparing products across insurers encountered materially different policy wordings, making genuine price-for-equivalent-coverage comparisons difficult. IRDAI recognised that complexity was itself a barrier to adoption, particularly among first-time insurance buyers.
IRDAI's circular of January 2021 required all life insurers to offer Saral Jeevan Bima as a standard product with a uniform product structure. Key standardised features: the policy provides a lump sum death benefit (sum assured) to the nominee if the insured dies during the policy term; no maturity benefit is payable (pure risk cover, no savings element); the minimum sum assured was set at Rs 5 lakh and the maximum at Rs 25 lakh; policy term options were defined as 5 to 40 years; and the minimum entry age was set at 18 years with a maximum of 65 years.
Crucially, IRDAI standardised the exclusions. Only two circumstances permit claim rejection: death by suicide within 12 months of policy inception, and material misrepresentation in the proposal form. All other causes of death — including pre-existing conditions disclosed at inception — are covered after standard waiting periods. This was a significant departure from the complex exclusion schedules in proprietary term products.
Riders allowed under Saral Jeevan Bima are limited to accidental death benefit and permanent disability benefit, preventing feature creep that historically made simple products opaque.
Insurers were required to price Saral Jeevan Bima independently of their other term products, and its premiums needed to be filed with and approved by IRDAI before launch. The standardisation ensured that customers could compare only on price (and insurer claim settlement ratio) rather than on hidden feature differences.
Market reception was positive among consumer advocates. Insurers who had previously competed on bundled add-ons found the product forced genuine actuarial pricing transparency. The product served as a model for subsequent standardisation exercises, including Arogya Sanjeevani in health insurance.